Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02991924

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

Risk Factors of Medistinal Metastasis in Endoscopic Medistinal Staging of Non-small Cell Lung Cancer

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
National Cancer Center, Korea · Other Government
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate risk factors for mediastinal lymph node metastasis in potentially operable non-small cell lung cancer in order to find indications for endoscopic mediastinal staging. Chest CT, integrated PET/CT, and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) +/- endoscopic ultrasound with bronchoscope-guided fine needle aspiration (EUS-B-FNA) are performed for mediastinal staging. CT and PET/CT findings, histologic types and other risk factors will be analyzed. The investigators develop the prediction method for mediastinal metastasis.

Conditions

Timeline

Start date
2016-07-01
Primary completion
2019-12-01
Completion
2026-07-01
First posted
2016-12-14
Last updated
2024-04-04

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02991924. Inclusion in this directory is not an endorsement.